Jay N Lozier
Overview
Explore the profile of Jay N Lozier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
652
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uy G, DeAngelo D, Lozier J, Fisher D, Jonas B, Magnani J, et al.
Blood Rev
. 2024 Mar;
65:101184.
PMID: 38493006
E-selectin, a cytoadhesive glycoprotein, is expressed on venular endothelial cells and mediates leukocyte localization to inflamed endothelium, the first step in inflammatory cell extravasation into tissue. Constitutive marrow endothelial E-selectin...
2.
Lozier J, Elinoff J, Suffredini A, Rosing D, Sidenko S, Sherry R, et al.
Blood Coagul Fibrinolysis
. 2018 Oct;
29(8):701-707.
PMID: 30300148
: Guidelines-recommend thrombolytic therapy for pulmonary embolism in patients with severe hemodynamic compromise and low risk of bleeding. Thrombolytics in submassive pulmonary embolism have an unfavorable risk/benefit ratio and remain...
3.
Gopalakrishnan V, Jones A, Julien-Williams P, Machado T, Danner R, Swigris J, et al.
ERJ Open Res
. 2018 Mar;
4(1).
PMID: 29577040
http://ow.ly/jPFz30iysgV.
4.
Keppler-Noreuil K, Lozier J, Sapp J, Biesecker L
Am J Med Genet A
. 2017 Jun;
173(9):2359-2365.
PMID: 28627093
Patients with overgrowth and complex vascular malformation syndromes, including Proteus syndrome have an increased risk of thromboembolism. Proteus syndrome is a mosaic, progressive overgrowth disorder involving vasculature, skin, and skeleton,...
5.
Lozier J, Kloos M, Merricks E, Lemoine N, Whitford M, Raymer R, et al.
Comp Med
. 2016 Oct;
66(5):405-411.
PMID: 27780008
Animals with hemophilia are models for gene therapy, factor replacement, and inhibitor development in humans. We have actively sought dogs with severe hemophilia A that have novel factor VIII mutations...
6.
Lipsky A, Lozier J, Wiestner A
Haematologica
. 2016 Mar;
101(3):e124-5.
PMID: 26928253
No abstract available.
7.
Sumner A, Duong M, Aldana P, Ricks M, Tulloch-Reid M, Lozier J, et al.
Diabetes Care
. 2015 Dec;
39(2):271-7.
PMID: 26681716
Objective: Slowing the diabetes epidemic in Africa requires improved detection of prediabetes. A1C, a form of glycated hemoglobin A, is recommended for diagnosing prediabetes. The glycated proteins, fructosamine and glycated...
8.
Lipsky A, Farooqui M, Tian X, Martyr S, Cullinane A, Nghiem K, et al.
Haematologica
. 2015 Oct;
100(12):1571-8.
PMID: 26430171
Ibrutinib is associated with bleeding-related adverse events of grade ≤ 2 in severity, and infrequently with grade ≥ 3 events. To investigate the mechanisms of bleeding and identify patients at...
9.
10.
Sauna Z, Lozier J, Kasper C, Yanover C, Nichols T, Howard T
Blood
. 2014 Nov;
125(2):223-8.
PMID: 25406352
Intron-22-inversion patients express the entire Factor VIII (FVIII)-amino-acid sequence intracellularly as 2 non-secreted polypeptides and have a positive "intracellular (I)-FVIII-CRM" status. Mutations conferring a positive I-FVIII-CRM status are associated with...